HMGB1 Expression Level in Circulating Platelets is not Significantly Associated with Outcomes in Symptomatic Coronary Artery Disease
Background/Aims: Platelets express high-mobility group box 1 (HMGB1), a damage-associated molecular pattern molecule (DAMP) that triggers thrombosis and inflammation when present in extracellular space. The role of platelet-derived HMGB1 in coronary artery disease (CAD) remains unexplored. Methods:...
Main Authors: | Dominik Rath, Tobias Geisler, Meinrad Gawaz, Sebastian Vogel |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-10-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/482026 |
Similar Items
-
Clinical Significance of Platelet Volume and Other Platelet Parameters in Acute Myocardial Infarction and Stable Coronary Artery Disease
by: Liumei Ding, et al.
Published: (2019-04-01) -
Impact of Intravenous P2Y12-Receptor Inhibition with Cangrelor in Patients Presenting with Acute Coronary Syndrome and Cardiogenic Shock – a Case Series
by: Michal Droppa, et al.
Published: (2017-07-01) -
Mean platelet volume and the extent of coronary atherosclerosis in patients with stable coronary artery disease
by: Adnan Karan, et al.
Published: (2013-02-01) -
The relation between platelet/lymphocyte ratio and the occurrence of no reflow in patients with ST-segment elevation myocardial infarction managed by primary percutaneous coronary intervention
by: Ahmed Mohamed El Missiri, et al.
Published: (2021-01-01) -
Balancing Potency of Platelet Inhibition with Bleeding Risk in the Early Treatment of Acute Coronary Syndrome
by: Slattery, David E, et al.
Published: (2009-08-01)